3004.90.92.17 - Containing amiodarone or its salts 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS classification covers pharmaceutical products that are medicaments for therapeutic or prophylactic use, packaged in measured doses or for retail sale, and specifically contain amiodarone or its salts. Amiodarone is an antiarrhythmic medication used to treat certain types of irregular heartbeats. This designation applies regardless of whether the amiodarone is the sole active ingredient or present in combination with other pharmaceutical substances, provided it meets the general requirements of heading 3004.
Distinguishing this category from its siblings, it is important to note that while all fall under "Cardiovascular medicaments," this specific sub-classification is solely for products containing amiodarone. For example, 3004.90.92.16 covers medicaments with metoprolol, 3004.90.92.18 with diltiazem, and 3004.90.92.19 with hydralazine. The selection of the correct sub-heading hinges on the precise identification of the active pharmaceutical ingredient present in the medicament.
As this is a leaf node in the HTS classification, there are no further subcategories. Therefore, the classification of a medicament into 3004.90.92.17 relies on the definitive presence of amiodarone or its salts as a key therapeutic component within a product otherwise qualifying as a medicament under heading 3004.